230 related articles for article (PubMed ID: 15389738)
1. Increased brain tumor resection using fluorescence image guidance in a preclinical model.
Bogaards A; Varma A; Collens SP; Lin A; Giles A; Yang VX; Bilbao JM; Lilge LD; Muller PJ; Wilson BC
Lasers Surg Med; 2004; 35(3):181-90. PubMed ID: 15389738
[TBL] [Abstract][Full Text] [Related]
2. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
3. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
4. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas.
Ma R; Watts C
Acta Neurochir (Wien); 2016 Oct; 158(10):1935-41. PubMed ID: 27496021
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
6. Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.
Suero Molina E; Stögbauer L; Jeibmann A; Warneke N; Stummer W
Acta Neurochir (Wien); 2020 Apr; 162(4):785-793. PubMed ID: 32034493
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study.
Utsuki S; Miyoshi N; Oka H; Miyajima Y; Shimizu S; Suzuki S; Fujii K
Brain Tumor Pathol; 2007; 24(2):53-5. PubMed ID: 18095131
[TBL] [Abstract][Full Text] [Related]
8. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects.
Colditz MJ; Leyen Kv; Jeffree RL
J Clin Neurosci; 2012 Dec; 19(12):1611-6. PubMed ID: 23059058
[TBL] [Abstract][Full Text] [Related]
9. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
10. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
11. [5-Aminolevulinic acid (ALA) and its applications in neurosurgery].
Grieb P
Neurol Neurochir Pol; 2004; 38(3):201-7. PubMed ID: 15354233
[TBL] [Abstract][Full Text] [Related]
12. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
13. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
14. [5-ALA fluorescence guided tumor resection].
Yamaguchi F; Teramoto A; Takahashi H
No To Shinkei; 2006 Dec; 58(12):1027-33. PubMed ID: 17193952
[No Abstract] [Full Text] [Related]
15. Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection.
Roberts DW; Olson JD; Evans LT; Kolste KK; Kanick SC; Fan X; Bravo JJ; Wilson BC; Leblond F; Marois M; Paulsen KD
J Neurosurg; 2018 Jun; 128(6):1690-1697. PubMed ID: 28777025
[TBL] [Abstract][Full Text] [Related]
16. Auditory alert system for fluorescence-guided resection of gliomas.
Utsuki S; Oka H; Miyajima Y; Shimizu S; Suzuki S; Fujii K
Neurol Med Chir (Tokyo); 2008 Feb; 48(2):95-7; discussion 97-8. PubMed ID: 18296881
[TBL] [Abstract][Full Text] [Related]
17. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
18. Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.
Haj-Hosseini N; Richter JC; Hallbeck M; Wårdell K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):209-14. PubMed ID: 25818546
[TBL] [Abstract][Full Text] [Related]
19. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development.
Bogaards A; Varma A; Zhang K; Zach D; Bisland SK; Moriyama EH; Lilge L; Muller PJ; Wilson BC
Photochem Photobiol Sci; 2005 May; 4(5):438-42. PubMed ID: 15875077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
